RE: Watch this space24 Apr 2021 16:55
Good post Energyshares. I don’t know the answer as to how many steps AVA6000 needs success in, in clinical trials, to trigger takeover activity. Perhaps initial trials, should they produce convincing results, would be sufficient to de-risk for an acquirer and possibly attract others. In this case we’d most likely see the SP react significantly, before results were published, so we will know.
Admittedly also the diagnostics business now seems to have a broader and v good future mid and long term aswell, aside from the unknowns of Covid 19. If we don’t end up with vast scale of LFT Covid orders we’d hoped for, the diagnostics will still be very valuable as a recurring revenue steam, for which we’ll be able to add big multiples.
The business is still looking extremely attractive no matter how much I’ve been trying to wean myself off thinking about it over the last few days.